“…A recent systematic review evaluated gender bias in 25 published randomized clinical trials (RCTs) on migraine prevention with CGRP-mAbs . In line with Porreca and Dodick, this systematic review showed that only 2 RCTs included a sex-based analysis, and none discussed the results separately for men and for women.…”